What is the appropriate evaluation and management for a patient with elevated urinary red blood cells and ketonuria?

Evaluation and Management of Elevated Urinary RBCs with Ketonuria

You need to address these as two separate clinical findings: the hematuria requires a complete urologic evaluation based on risk stratification, while the ketonuria demands immediate assessment for diabetic ketoacidosis or other metabolic causes.

Immediate Assessment for Ketonuria

The presence of ketones in urine is highly sensitive for diabetic ketoacidosis (DKA) or significant ketosis and requires urgent evaluation 1. Check blood glucose immediately - if elevated with symptoms (abdominal pain, nausea), this is a medical emergency requiring assessment for DKA 1.

Key Actions for Ketones:

• Measure blood glucose and serum electrolytes to rule out DKA
• Assess for symptoms: nausea, abdominal pain, altered mental status
• If diabetic: implement sick day rules and seek immediate medical attention if ketones are elevated 1
• If non-diabetic: consider starvation ketosis, alcoholic ketoacidosis, or ketogenic diet

Important caveat: Urine ketone testing primarily detects acetoacetate but may underestimate total ketone burden since β-hydroxybutyrate (the predominant ketone in DKA) may not be adequately measured 1. Blood ketone testing is more accurate if available.

Hematuria Evaluation - Risk Stratification Approach

Once metabolic issues are addressed, evaluate the hematuria systematically using the 2020 AUA risk-based framework 2.

Step 1: Confirm True Hematuria

Obtain microscopic urinalysis - dipstick alone is insufficient (specificity only 65-99%) 3. The definition of microscopic hematuria is ≥3 RBCs per high-power field on microscopic examination of properly collected urine from 2 of 3 specimens 3.

Step 2: Exclude Benign Transient Causes

Repeat urinalysis 48 hours after cessation if history suggests:

• Vigorous exercise
• Menstruation
• Recent sexual activity
• Recent urologic procedure
• Urinary tract infection (treat first, recheck in 6 weeks) 4, 3

If hematuria resolves, no further evaluation needed 3.

Step 3: Assess for Glomerular vs. Non-Glomerular Source

Examine urine sediment for 3:

• Dysmorphic RBCs (>80% suggests glomerular origin)
• RBC casts (pathognomonic for glomerular disease)
• Significant proteinuria (≥2+ on dipstick)
• Elevated serum creatinine

If glomerular features present: Refer to nephrology immediately for potential renal biopsy 3, 5. Check blood pressure, consider autoimmune workup.

Step 4: Risk Stratification for Urologic Malignancy

The 2020 AUA guidelines stratify patients into three risk tiers 2:

High-Risk Factors 3:

• Age >40 years (especially males)
• Smoking history (current or former)
• Occupational exposure to chemicals/dyes (benzenes, aromatic amines)
• History of gross hematuria
• History of pelvic irradiation
• Chronic UTIs
• Analgesic abuse
• Irritative voiding symptoms
• History of urologic disease

Evaluation Based on Risk:

Low-Risk Patients (no risk factors, <10 RBCs/HPF):

• May defer complete evaluation with shared decision-making
• Annual urinalysis monitoring acceptable 2

Intermediate/High-Risk Patients: Complete urologic evaluation required 3:

1. Upper tract imaging: CT urography preferred (detects renal cell carcinoma, transitional cell carcinoma, stones) 4. Alternatives include MR urography or renal ultrasound plus retrograde pyelography if CT contraindicated.

2. Cystoscopy: Essential to evaluate bladder and urethra for transitional cell carcinoma 3

3. Urine cytology: Recommended for high-risk patients (especially smokers, age >40, irritative symptoms) 3. Useful adjunct to cystoscopy for detecting carcinoma in situ.

Step 5: Nephrology Referral Indications

Refer to nephrology if 5, 6:

• eGFR <30 mL/min/1.73 m²
• Persistent albuminuria (ACR ≥300 mg/g or ≥60 mg/mmol)
• RBC casts present

• 20 RBCs/HPF sustained and unexplained

• Dysmorphic RBCs >5% (acanthocytes)
• Proteinuria with hematuria
• Refractory hypertension with CKD
• Unexplained decline in eGFR >20%

Common Pitfalls to Avoid

1. Don't ignore ketonuria - it may indicate life-threatening DKA, especially if patient is diabetic or on SGLT2 inhibitors 1

2. Don't rely on dipstick alone for hematuria diagnosis - requires microscopic confirmation 3

3. Don't skip evaluation in patients on anticoagulation - bleeding risk doesn't exclude malignancy; full evaluation still warranted 4

4. Don't use urine cytology as sole screening tool - sensitivity is limited; cystoscopy remains gold standard 3

5. Don't forget to recheck after treating UTI - persistent hematuria after infection treatment requires full evaluation 3

Follow-Up After Negative Evaluation

If initial workup is negative but hematuria persists, repeat urinalysis annually 2. Reinitiate evaluation if:

• Gross hematuria develops
• Significant increase in degree of microscopic hematuria
• New urologic symptoms appear
• Risk factors change 2

The diagnostic yield of repeated evaluations is very low, but changes in clinical status warrant reassessment 2.